That’s nearly 50 million doses a year, Sørensen said.

“Of course we don’t have stockpiles available for the entire planet, but just in the midterm and long term we will have quite a large capacity to produce vaccines,” he said. “We’re talking to a large number of countries that are putting in procurement requests to us as the problem is just spreading and increasing day by day,” said Rolf Sass Sørensen, the company’s vice president for investor relations and communication.īavarian Nordic is confident it can supply the doses needed - if the immediate and acute demand doesn’t skyrocket. “This basically is the largest cluster of monkeypox cases happening in multiple countries simultaneously outside of an endemic region,” said Boghuma Kabisen Titanji, a Cameroonian doctor based at Emory University in Atlanta.īavarian Nordic, the manufacturer of the monkeypox vaccine Jynneos approved by the Food and Drug Administration, told POLITICO that it has received calls from “many, many countries” wishing to purchase its shot.